Pulmuone Corporate (KRX:017810)
South Korea
· Delayed Price · Currency is KRW 11,950
+360 (3.11%)
Mar 10, 2026, 3:30 PM KST
Pulmuone Corporate Revenue
Pulmuone Corporate had revenue of 888.40B KRW in the quarter ending September 30, 2025, with 6.57% growth. This brings the company's revenue in the last twelve months to 3.34T, up 5.72% year-over-year. In the year 2024, Pulmuone Corporate had annual revenue of 3.21T with 7.36% growth.
Revenue (ttm)
3,338.70B
Revenue Growth
+5.72%
P/S Ratio
0.13
Revenue / Employee
6.57B
Employees
508
Market Cap
427.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3,213.70B | 220.23B | 7.36% |
| Dec 31, 2023 | 2,993.47B | 155.16B | 5.47% |
| Dec 31, 2022 | 2,838.30B | 319.41B | 12.68% |
| Dec 31, 2021 | 2,518.90B | 207.70B | 8.99% |
| Dec 31, 2020 | 2,311.20B | -70.25B | -2.95% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nongshim Holdings | 802.99B |
| Samyang | 2,604.05B |
| SPC Samlip | 3,404.12B |
| EASY HOLDINGS | 3,385.10B |
| Daesang Holdings | 5,623.06B |
| Namyang Dairy Products | 916.64B |
| Kwang Dong Pharmaceutical | 1,638.24B |
| Sajodaerim | 3,478.58B |